Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
The data show that mesutoclax demonstrates outstanding efficacy and safety in treating various hematologic malignancies.
-
Envetec approval creates new alternative to centralized medical waste treatment in Massachusetts.
-
Two of the world’s leading specialist healthcare investors with over $21 billion AUM are joining forces to create the largest dedicated healthcare investment manager globallyTogether, the group will...
-
Two of the world’s leading specialist healthcare investors with over $21 billion AUM are joining forces to create the largest dedicated healthcare investment manager globallyTogether, the group will...
-
PONTE VEDRA, Fla., May 19, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and...
-
ALBANY, N.Y., May 19, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of its upgrade to its...
-
60 Degrees Pharmaceuticals Announces First Quarter 2026 Results
-
Kneat announces record revenue for Q1 2026 of $18 million, up 18% from Q1 2025, and accelerating gross profit growth of 28% year-over-year.
-
DYADIC ANNOUNCES FIRST QUARTER 2026 FINANCIAL RESULTS AND HIGHLIGHTS RECENT COMPANY PROGRESS
-
AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (T2DM) rank among the most urgent and costly healthcare problems facing the world...